GH1 and adenoma: The OTL38 patient subgroup of the mentioned study by Cho et al. [16] consisted of 23 patients (14 non-functioning adenomas, three GH-secreting, and six ACTH-secreting adenomas) and received OTL38 2–4 h preoperatively.